Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Hematological malignancies in Al-amal oncology unit, aden.

Al-Kahiry W.

Indian J Hematol Blood Transfus. 2012 Mar;28(1):19-23. doi: 10.1007/s12288-011-0101-3. Epub 2011 Aug 18.

2.
3.

[Bone marrow involvement in hematologic neoplasms and solid tumors].

Martin S, Germing U, Kronenwett R, Haas R.

Radiologe. 2000 Aug;40(8):675-80. Review. German.

PMID:
11006936
4.

Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies. Nagoya CD34+ PBSCT Study Group.

Ogura M, Kagami Y, Suzuki R, Miura K, Uehira K, Kurokawa T, Ito T, Kinoshita T, Emi N, Morishima Y, Kodera Y, Ueda R.

Cancer Chemother Pharmacol. 1997;40 Suppl:S51-7.

PMID:
9272135
5.

Significance of bone marrow stromal cells in hematopoiesis and hematological disorders.

Nagao T.

Tokai J Exp Clin Med. 1995 Jul;20(2):121-30. Review.

PMID:
8797268
6.

Primary lymphomas of bone.

Kitsoulis P, Vlychou M, Papoudou-Bai A, Karatzias G, Charchanti A, Agnantis NJ, Bai M.

Anticancer Res. 2006 Jan-Feb;26(1A):325-37. Review.

7.

A multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: Hematological malignancies, the unusual cause of pancytopenia in patients with brucellosis.

Sari I, Altuntas F, Hacioglu S, Kocyigit I, Sevinc A, Sacar S, Deniz K, Alp E, Eser B, Yildiz O, Kaynar L, Unal A, Cetin M.

Am J Hematol. 2008 Apr;83(4):334-9.

8.

Stem cell regulatory niches and their role in normal and malignant hematopoiesis.

Carlesso N, Cardoso AA.

Curr Opin Hematol. 2010 Jul;17(4):281-6. doi: 10.1097/MOH.0b013e32833a25d8. Review.

PMID:
20473160
10.

Management of paediatric lymphoma.

Philip T, Bergeron C, Frappaz D.

Baillieres Clin Haematol. 1996 Dec;9(4):769-97. Review.

PMID:
9138617
11.

In vitro hematopoiesis in patients with malignant lymphoma during active disease and at complete clinical remission after chemotherapy.

Huerta-Zepeda A, Talavera A, Avil├ęs A, Neri N, Mayani H.

Leuk Lymphoma. 2000 Nov;39(5-6):613-24.

PMID:
11342345
12.
13.

Granulopoiesis in newly diagnosed childhood solid tumors.

Liang DC, Chen SH, Liu HC, Yu SF, Kuo MC.

Pediatr Hematol Oncol. 1997 Sep-Oct;14(5):423-31.

PMID:
9267874
14.

Special Education: Aplastic Anemia.

Teramura M, Mizoguchi H.

Oncologist. 1996;1(3):187-189.

15.

Cytogenetic and molecular cytogenetic profile of bone marrow-derived mesenchymal stromal cells in chronic and acute lymphoproliferative disorders.

Campioni D, Bardi MA, Cavazzini F, Tammiso E, Pezzolo E, Pregnolato E, Volta E, Cuneo A, Lanza F.

Ann Hematol. 2012 Oct;91(10):1563-77. doi: 10.1007/s00277-012-1500-8. Epub 2012 Jun 14.

PMID:
22696050
16.

Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions.

Orfao A, Schmitz G, Brando B, Ruiz-Arguelles A, Basso G, Braylan R, Rothe G, Lacombe F, Lanza F, Papa S, Lucio P, San Miguel JF.

Clin Chem. 1999 Oct;45(10):1708-17. Review.

17.
18.

Elevated levels of soluble interleukin-2 receptor in serum of patients with hematological or non-hematological malignancies.

Nakase K, Tsuji K, Tamaki S, Tanigawa M, Ikeda T, Miyanishi E, Shiku H.

Cancer Detect Prev. 2005;29(3):256-9.

PMID:
15899555
19.

Survival of patients with hematological malignancy admitted to the intensive care unit: prognostic factors and outcome compared to unselected medical intensive care unit admissions, a parallel group study.

Hill QA, Kelly RJ, Patalappa C, Whittle AM, Scally AJ, Hughes A, Ashcroft AJ, Hill A.

Leuk Lymphoma. 2012 Feb;53(2):282-8. doi: 10.3109/10428194.2011.614705. Epub 2011 Sep 29.

PMID:
21846185
20.

Nutritional status among pediatric cancer patients: a comparison between hematological malignancies and solid tumors.

Tah PC, Nik Shanita S, Poh BK.

J Spec Pediatr Nurs. 2012 Oct;17(4):301-11. doi: 10.1111/j.1744-6155.2012.00341.x.

PMID:
23009042

Supplemental Content

Support Center